These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15509165)

  • 1. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
    Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in the structure-activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski AM; Joseph CG; Haskell-Luevano C
    Med Res Rev; 2005 Sep; 25(5):545-56. PubMed ID: 16044415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
    Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
    Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
    Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
    Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
    Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
    Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
    Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
    Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
    Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongation studies of the human agouti-related protein (AGRP) core decapeptide (Yc[CRFFNAFC]Y) results in antagonism at the mouse melanocortin-3 receptor.
    Joseph CG; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Haskell-Luevano C
    Peptides; 2003 Feb; 24(2):263-70. PubMed ID: 12668211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein.
    McNulty JC; Thompson DA; Bolin KA; Wilken J; Barsh GS; Millhauser GL
    Biochemistry; 2001 Dec; 40(51):15520-7. PubMed ID: 11747427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The melanocortin system in Fugu: determination of POMC/AGRP/MCR gene repertoire and synteny, as well as pharmacology and anatomical distribution of the MCRs.
    Klovins J; Haitina T; Fridmanis D; Kilianova Z; Kapa I; Fredriksson R; Gallo-Payet N; Schiöth HB
    Mol Biol Evol; 2004 Mar; 21(3):563-79. PubMed ID: 14694081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Agouti-related protein binding to melanocortin receptors.
    Yang YK; Thompson DA; Dickinson CJ; Wilken J; Barsh GS; Kent SB; Gantz I
    Mol Endocrinol; 1999 Jan; 13(1):148-55. PubMed ID: 9892020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity.
    Jackson PJ; McNulty JC; Yang YK; Thompson DA; Chai B; Gantz I; Barsh GS; Millhauser GL
    Biochemistry; 2002 Jun; 41(24):7565-72. PubMed ID: 12056887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of the agouti signaling protein.
    McNulty JC; Jackson PJ; Thompson DA; Chai B; Gantz I; Barsh GS; Dawson PE; Millhauser GL
    J Mol Biol; 2005 Mar; 346(4):1059-70. PubMed ID: 15701517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.